Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each These subcutaneous examples come from informal research discussions
The healing peptide stack Based on Rogan's discussions and broader research community practices, healing protocols often combine: BPC-157 for local tissue repair, often injected near the injury site
Do not rely on this method to decide whether you are over the legal limit to drive
Lean mass rose as a share of total weight, and grip strength improved on semaglutide. Protein, resistance training, and strength trends provide more useful context than the scan ratio alone
rda: PMID: 23755725 przegld dotyczcy relacji BPC-157 z ukadem NO, cytoprotekcj i gojeniem tkanek
Our Canadian-based team can answer specific research questions